Catalyst Wire Dossier Catalyst Wire Dossier

Bupropion hydrochloride extended-release tablet

bupropion hydrochloride extended-release · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bupropion hydrochloride extended-release tablet, covering 2019-02-18 to 2019-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder [Phase 3]

See pricing